[1] Laster SB, O'Keefe JH Jr, Gibbons RJ, et al.Incidence and importance of thrombolvsis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardialinfarction[J].Am J Cardiol, 1996, 78(6):623-626.
[2] Ndrepepa G, Tiroch K, Fusaro M, et al.5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction[J].J Am Coll Cardiol, 2010, 55(21):2383-2389.
[3] Di Sciascio G, Patti G, Pasceri V, et al.Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE(Atorvastatin for Reduction of Myocardial during Angioplasty) Randomized Trial[J].J Am Coll Cardiol, 2009, 54(6):558-565.
[4] Briguori C, Visconti G, Focaccio A, et al.Novel approaches for preventing or limiting events(Naples)Ⅱ trial:impact of a single high loading dose of atorvastation on periprocedural myocardial infarction[J].J Am Coll Cardiol, 2009, 54(23):2157-2163.
[5] 罗育坤, 林朝贵, 范林, 等.阿托伐他汀序贯治疗择期经皮冠状动脉介入患者的有效性和安全性[J].中国动脉硬化杂志, 2012, 20(9):824-828.
[6] Antoniucci D, Migliorini A, Parodi G, et al.Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival:a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone[J].Circulation, 2004, 109(14):1704-1706.
[7] Lefkovits J, Plow EF, Topol EJ.Platelet glycoprotein Ⅱb/Ⅲa receptors in cardiovascular medicine[J].N Engl J Med, 1995, 332(23):1553-1559.
[8] Heitzer T, Ollmann I, Köke K, et al.Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease[J].Circulation, 2003, 108(5):536-541.
[9] 郑博, 王新刚, 龚艳君, 等.直接经皮冠状动脉介入治疗术前负荷剂量阿托伐他汀治疗对急性心肌梗死患者近期预后的影响[J].中国介入心脏病学杂志, 2013, 21(1):41-45.
[10] Kim JS, Kim J, Choi D, et al.Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction:the STATIN STEMI trial[J].JACC Cardiovasc Interv, 2010, 3(3):332-339.
[11] 曾繁芳, 刘幼文, 金光临, 等.阿托伐他汀序贯疗法对冠状动脉支架置入术后患者预后的影响[J].广东医学, 2011, 32(4):508-510.
[12] Liu HL, Yang Y, Yang SL, et al.Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients:a randomized clinical study[J].Clin Ther, 2013, 35(3):261-272.
[13] Ray KK, Cannon CP.Intensive statin therapy for treating acute coronary syndromes[J].Expert Opin Investig Drugs, 2006, 15(10):1151-1159.
[14] Warnholtz A, Ostad M A, Heitzer T, et al.Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J].Am J Cardiol, 2005, 95(1):20-23.